| pubmed-article:19740617 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19740617 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19740617 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
| pubmed-article:19740617 | lifeskim:mentions | umls-concept:C0600139 | lld:lifeskim |
| pubmed-article:19740617 | lifeskim:mentions | umls-concept:C0178415 | lld:lifeskim |
| pubmed-article:19740617 | lifeskim:mentions | umls-concept:C0205082 | lld:lifeskim |
| pubmed-article:19740617 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
| pubmed-article:19740617 | lifeskim:mentions | umls-concept:C0024485 | lld:lifeskim |
| pubmed-article:19740617 | lifeskim:mentions | umls-concept:C0037812 | lld:lifeskim |
| pubmed-article:19740617 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:19740617 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:19740617 | pubmed:dateCreated | 2011-1-31 | lld:pubmed |
| pubmed-article:19740617 | pubmed:abstractText | To assess the ability of combined whole-prostate magnetic resonance imaging and magnetic resonance spectroscopy imaging (MRI+MRSI) to predict the presence or absence of high grade (Gleason 4+3 or higher) prostate carcinoma in men with elevated PSA. | lld:pubmed |
| pubmed-article:19740617 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19740617 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19740617 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19740617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19740617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19740617 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19740617 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:19740617 | pubmed:issn | 1872-7727 | lld:pubmed |
| pubmed-article:19740617 | pubmed:author | pubmed-author:OosterlinckWi... | lld:pubmed |
| pubmed-article:19740617 | pubmed:author | pubmed-author:De... | lld:pubmed |
| pubmed-article:19740617 | pubmed:author | pubmed-author:VilleirsGeert... | lld:pubmed |
| pubmed-article:19740617 | pubmed:author | pubmed-author:De... | lld:pubmed |
| pubmed-article:19740617 | pubmed:author | pubmed-author:FonteyneValer... | lld:pubmed |
| pubmed-article:19740617 | pubmed:author | pubmed-author:VerbaeysAnton... | lld:pubmed |
| pubmed-article:19740617 | pubmed:copyrightInfo | Copyright © 2009 Elsevier Ireland Ltd. All rights reserved. | lld:pubmed |
| pubmed-article:19740617 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19740617 | pubmed:volume | 77 | lld:pubmed |
| pubmed-article:19740617 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19740617 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19740617 | pubmed:pagination | 340-5 | lld:pubmed |
| pubmed-article:19740617 | pubmed:meshHeading | pubmed-meshheading:19740617... | lld:pubmed |
| pubmed-article:19740617 | pubmed:meshHeading | pubmed-meshheading:19740617... | lld:pubmed |
| pubmed-article:19740617 | pubmed:meshHeading | pubmed-meshheading:19740617... | lld:pubmed |
| pubmed-article:19740617 | pubmed:meshHeading | pubmed-meshheading:19740617... | lld:pubmed |
| pubmed-article:19740617 | pubmed:meshHeading | pubmed-meshheading:19740617... | lld:pubmed |
| pubmed-article:19740617 | pubmed:meshHeading | pubmed-meshheading:19740617... | lld:pubmed |
| pubmed-article:19740617 | pubmed:meshHeading | pubmed-meshheading:19740617... | lld:pubmed |
| pubmed-article:19740617 | pubmed:meshHeading | pubmed-meshheading:19740617... | lld:pubmed |
| pubmed-article:19740617 | pubmed:meshHeading | pubmed-meshheading:19740617... | lld:pubmed |
| pubmed-article:19740617 | pubmed:meshHeading | pubmed-meshheading:19740617... | lld:pubmed |
| pubmed-article:19740617 | pubmed:meshHeading | pubmed-meshheading:19740617... | lld:pubmed |
| pubmed-article:19740617 | pubmed:meshHeading | pubmed-meshheading:19740617... | lld:pubmed |
| pubmed-article:19740617 | pubmed:meshHeading | pubmed-meshheading:19740617... | lld:pubmed |
| pubmed-article:19740617 | pubmed:meshHeading | pubmed-meshheading:19740617... | lld:pubmed |
| pubmed-article:19740617 | pubmed:meshHeading | pubmed-meshheading:19740617... | lld:pubmed |
| pubmed-article:19740617 | pubmed:meshHeading | pubmed-meshheading:19740617... | lld:pubmed |
| pubmed-article:19740617 | pubmed:meshHeading | pubmed-meshheading:19740617... | lld:pubmed |
| pubmed-article:19740617 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:19740617 | pubmed:articleTitle | Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients. | lld:pubmed |
| pubmed-article:19740617 | pubmed:affiliation | Department of Radiology, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium. Geert.Villeirs@UGent.be | lld:pubmed |
| pubmed-article:19740617 | pubmed:publicationType | Journal Article | lld:pubmed |
